Video: Stereotactic ablative body radiotherapy for inoperable primary kidney cancer
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer Abstract Objective To assess the feasibility and safety of stereotactic ablative body radiotherapy (SABR) for renal cell carcinoma (RCC) in patients unsuitable for surgery. Secondary objectives were to assess oncological and functional outcomes. Materials and Methods This was a prospective interventional clinical trial with institutional ethics […]